Latest AI and machine learning research in liver transplantation for healthcare professionals.
Synthesizing medical images remains challenging due to limited annotated pathological data, modali...
The study by Huang , published in the , advances intrahepatic cholangiocarcinoma (ICC) management by...
The study by Huang , published in the , advances intrahepatic cholangiocarcinoma (ICC) management by...
AIM: This case series aimed to explore the occurrence of synchronous hepatocellular carcinoma (HCC) ...
Liver cirrhosis is an insidious condition involving the substitution of normal liver tissue with f...
BACKGROUND: Hepatic fibrosis (HF) represents a pivotal stage in the progression and potential revers...
The segmentation of multiple organs in multi-parametric MRI studies is critical for many applicati...
BACKGROUND: Severe esophagogastric varices (EGVs) significantly affect prognosis of patients with he...
Chronic hepatitis B (CHB) infection represents a significant global public health issue, often leadi...
Crohn's disease and intestinal tuberculosis share many overlapping features such as clinical, radi...
Background: Recruitment for cohorts involving complex liver diseases, such as hepatocellular carci...
We present an end-to-end deep learning framework for automated liver cirrhosis stage estimation fr...
BACKGROUND AND AIM: Discriminating between idiosyncratic drug-induced liver injury (DILI) and autoim...
Hepatitis C virus infection is a significant global health concern, affecting millions worldwide. Al...
BACKGROUND: The incidence of metabolic dysfunction-associated steatohepatitis (MASH) is increasing a...
Longitudinal MRI analysis is crucial for predicting disease outcomes, particularly in chronic cond...
Tissue microenvironments reprogram local cellular states in disease, yet current computational spati...
Since ancient hepatitis B virus (HBV) sequencing data are scarce and incomplete, the evolutionary dy...
Despite its potential in cancer therapy, single-atom nanozyme (SAzyme) faces challenges like low ato...
Despite improved outcomes with atezolizumab plus bevacizumab (A+B) in hepatocellular carcinoma (HCC)...
Metabolic dysfunction–associated steatotic liver disease (MASLD) often coexists with chronic hepatit...